SLC39A8 and glioblastoma: Additionally, SLC39A8 (Supplementary Figure S1) exhibited significant overexpression in adrenocortical carcinoma (ACC), COAD, DLBC, ESCA, glioblastoma multiforme (GBM), KIRP, READ, STAD, TGCT, THYM, and UCEC, while its downregulation was observed in LUAD and LUSC.